Affiliation:
1. Moscow State University of Medicine and Dentistry Named after A.I.Evdokimov; City Clinical Hospital №52
2. Moscow State University of Medicine and Dentistry Named after A.I.Evdokimov
3. Medical Center «Med Garant»
Abstract
Disorders in the kidneys lead to disturbance of homeostasis. As the glomerular filtration rate decreases, the metabolism of numerous biologically active substances, including pituitary hormones, decreases. The article presents an overview of pituitary dysfunction in patients with chronic kidney disease (CKD) and discusses the possible reasons of the pathogenetic mechanisms. Particular focus is being given to the assessment of changes in the concentration of pituitary hormones in patients with end-stage chronic kidney disease (CKD) and discusses the pathogenetic mechanisms of their formation. Particular attention is paid to the assessment of changes in the concentration of pituitary hormones in patients receiving renal replacement therapy (RRT). CKD leads to an increase in the level of prolactin, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Concentrations of growth hormone (GH), isulin-like growth factor-1 (IGF-1), thyroid-stimulating hormone (TSH), adrenocorticotropic hormone (ACTH) and vasopressin may remain within normal values or increase in this group of patients. RRT does not reduce the levels of prolactin, LH, FSH, while the concentration of growth hormone, IGF-1, TSH tends to normalize. The content of ACTH and vasopressin may remain unchanged or decrease. Kidney transplantation in most cases corrects hormonal disorders. Correction of hormonal changes can improve the clinical outcome and quality of life of patients with end stage CKD.
Publisher
Endocrinology Research Centre
Subject
Endocrinology, Diabetes and Metabolism
Reference59 articles.
1. Smirnov AV, Shilov EM, Dobronravov VA, et al. National guidelines. Chronic Kidney disease: basic principles of screening, diagnosis, prevention and treatment approaches. Nephrology. 2012;16(1):89-115. (In Russ.)]. doi: https://doi.org/10.24884/1561-6274-2012-16-1-89-115
2. Hill NR, Fatoba ST, Oke JL et al. Global Prevalence of Chronic Kidney Disease — A Systematic Review and Meta-Analysis. PLoS One. 2016;11(7):e0158765. doi: https://doi.org/10.1371/journal.pone.0158765
3. Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052-2090. doi: https://doi.org/10.1016/S0140-6736(18)31694-5
4. Hronicheskaja bolezn’ pochek: uchebnoe posobie. Ed by Nikitin IG, Reznik EV, Zajvaja MV, et al. Moscow: RNIMU im.N.I.Pirogova Minzdrava Rossii; 2019 (In Russ.).
5. Niemczyk S, Niemczyk L, Romejko-Ciepielewska K. Basic endocrinological disorders in chronic renal failure. Endokrynol Pol. 2012;63(3):250-257.